Melita B. Irving
Melita B. Irving is from Canada. She studied biology at the University of Waterloo in Ontario and subsequently obtained her PhD in molecular biology and biochemistry at Simon Fraser University in British Columbia. She then went on to a post-doctoral project with Dr. Peter Lansdorp at the Terry Fox Laboratory in Vancouver, British Columbia before joining the group of Dr. Olivier Michielin in Lausanne, Switzerland. Her current post-doctoral research project in cancer immunotherapy involves the optimization and characterization of anti-cancer T-cell receptors (TCRs).